Skip to main content
Erschienen in: Endocrine Pathology 1/2019

02.01.2019

In Situ Hybridization Analysis of Long Non-coding RNAs MALAT1 and HOTAIR in Gastroenteropancreatic Neuroendocrine Neoplasms

verfasst von: Ying-Hsia Chu, Heather Hardin, Jens Eickhoff, Ricardo V. Lloyd

Erschienen in: Endocrine Pathology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Recent studies suggest onco-regulatory roles for two long non-coding RNAs (lncRNAs), MALAT1 and HOTAIR, in various malignancies; however, these lncRNAs have not been previously examined in neuroendocrine neoplasms (NENs) of gastroenteropancreatic origins (GEP-NENs). In this study, we evaluated the expressions and prognostic significance of MALAT1 and HOTAIR in 83 cases of GEP-NENs (60 grade 1, 17 grade 2, and 6 grade 3 tumors) diagnosed during the years 2005–2017. Expression levels of MALAT1 and HOTAIR were digitally quantitated in assembled tissue microarray slides labeled by chromogenic in situ hybridization (ISH) using InForm 1.4.0 software. We found diffuse nuclear expression of both HOTAIR and MALAT1 in all primary tumors of GEP-NENs with variable intensities. By multivariate model which adjusted for age and histologic grade, high expression of HOTAIR was associated with lower presenting T and M stages and subsequent development of metastases (P < 0.05). MALAT1 expression was associated with presenting T stage and development of metastases (P < 0.05). In summary, MALAT1 and HOTAIR are commonly expressed in GEP-NENs. High expression of either lncRNA showed grade-independent associations with clinically less aggressive disease.
Literatur
1.
Zurück zum Zitat Ohike N, Adsay NV, La Rosa S, Volante M, Zamboni G. 2017. WHO Classification of Tumours of Endocrine Organs, 10 ed. WHO Press, World Health Organization, Geneva. Ohike N, Adsay NV, La Rosa S, Volante M, Zamboni G. 2017. WHO Classification of Tumours of Endocrine Organs, 10 ed. WHO Press, World Health Organization, Geneva.
2.
Zurück zum Zitat Coriat R, Walter T, Terris B, Couvelard A, Ruszniewski P. 2016. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement. Oncologist 21:1191–1199.CrossRef Coriat R, Walter T, Terris B, Couvelard A, Ruszniewski P. 2016. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement. Oncologist 21:1191–1199.CrossRef
3.
Zurück zum Zitat Oberg K. 2009. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). Curr Opin Endocrinol Diabetes Obes 16:72–78.CrossRef Oberg K. 2009. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). Curr Opin Endocrinol Diabetes Obes 16:72–78.CrossRef
4.
Zurück zum Zitat Lewis MA, Yao JC. 2014. Molecular pathology and genetics of gastrointestinal neuroendocrine tumours. Current Opinion in Endocrinology, Diabetes and Obesity 21:22–27.CrossRef Lewis MA, Yao JC. 2014. Molecular pathology and genetics of gastrointestinal neuroendocrine tumours. Current Opinion in Endocrinology, Diabetes and Obesity 21:22–27.CrossRef
5.
Zurück zum Zitat Amair-Pinedo F, Matos I, Sauri T, Hernando J, Capdevila J. 2017. The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors. Target Oncol 12:757–774.CrossRef Amair-Pinedo F, Matos I, Sauri T, Hernando J, Capdevila J. 2017. The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors. Target Oncol 12:757–774.CrossRef
6.
Zurück zum Zitat Thorns C, Schurmann C, Gebauer N, et al. 2014. Global microRNA profiling of pancreatic neuroendocrine neoplasias. Anticancer Res 34:2249–2254.PubMed Thorns C, Schurmann C, Gebauer N, et al. 2014. Global microRNA profiling of pancreatic neuroendocrine neoplasias. Anticancer Res 34:2249–2254.PubMed
7.
Zurück zum Zitat Malczewska A, Kidd M, Matar S, Kos-Kudla B, Modlin IM. 2018. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology 107:73–90.CrossRef Malczewska A, Kidd M, Matar S, Kos-Kudla B, Modlin IM. 2018. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology 107:73–90.CrossRef
8.
Zurück zum Zitat Yoon JH, Abdelmohsen K, Gorospe M. 2013. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol 425:3723–3730.CrossRef Yoon JH, Abdelmohsen K, Gorospe M. 2013. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol 425:3723–3730.CrossRef
9.
Zurück zum Zitat Rinn JL, Chang HY. 2012. Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145–166.CrossRef Rinn JL, Chang HY. 2012. Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145–166.CrossRef
10.
Zurück zum Zitat Yang Y, Junjie P, Sanjun C, Ma Y. 2017. Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions. J Cancer 8:3212–3225.CrossRef Yang Y, Junjie P, Sanjun C, Ma Y. 2017. Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions. J Cancer 8:3212–3225.CrossRef
11.
Zurück zum Zitat Modali SD, Parekh VI, Kebebew E, Agarwal SK. 2015. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. Mol Endocrinol 29:224–237.CrossRef Modali SD, Parekh VI, Kebebew E, Agarwal SK. 2015. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. Mol Endocrinol 29:224–237.CrossRef
12.
Zurück zum Zitat Parekh VI, Modali SD, Desai SS, Agarwal SK. 2015. Consequence of Menin Deficiency in Mouse Adipocytes Derived by In Vitro Differentiation. Int J Endocrinol 2015:149826.CrossRef Parekh VI, Modali SD, Desai SS, Agarwal SK. 2015. Consequence of Menin Deficiency in Mouse Adipocytes Derived by In Vitro Differentiation. Int J Endocrinol 2015:149826.CrossRef
13.
Zurück zum Zitat Wei YL, Hua J, Liu XY, Hua XM, Sun C, Bai JA, Tang QY 2018. LncNEN885 inhibits epithelial-mesenchymal transition by partially regulation of Wnt/beta-catenin signalling in gastroenteropancreatic neuroendocrine neoplasms. Cancer Sci 109:3139–3148.CrossRef Wei YL, Hua J, Liu XY, Hua XM, Sun C, Bai JA, Tang QY 2018. LncNEN885 inhibits epithelial-mesenchymal transition by partially regulation of Wnt/beta-catenin signalling in gastroenteropancreatic neuroendocrine neoplasms. Cancer Sci 109:3139–3148.CrossRef
14.
Zurück zum Zitat Pang EJ, Yang R, Fu XB, Liu YF. 2015. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol 36:2403–2407.CrossRef Pang EJ, Yang R, Fu XB, Liu YF. 2015. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol 36:2403–2407.CrossRef
15.
Zurück zum Zitat Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P, Gu WL, Cai GX, Cai SJ 2014. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 7:3174–3181.PubMedPubMedCentral Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P, Gu WL, Cai GX, Cai SJ 2014. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 7:3174–3181.PubMedPubMedCentral
16.
Zurück zum Zitat Wu ZH, Wang XL, Tang HM, et al. 2014. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 32:395–402.CrossRef Wu ZH, Wang XL, Tang HM, et al. 2014. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 32:395–402.CrossRef
17.
Zurück zum Zitat Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S 2013. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32:1616–1625.CrossRef Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S 2013. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32:1616–1625.CrossRef
18.
Zurück zum Zitat Emadi-Andani E, Nikpour P, Emadi-Baygi M, Bidmeshkipour A. 2014. Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis. Adv Biomed Res 3:135.CrossRef Emadi-Andani E, Nikpour P, Emadi-Baygi M, Bidmeshkipour A. 2014. Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis. Adv Biomed Res 3:135.CrossRef
19.
Zurück zum Zitat Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY, Xue WQ, Chen YB, Zhang Y, Jia WH 2013. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci 104:1675–1682.CrossRef Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY, Xue WQ, Chen YB, Zhang Y, Jia WH 2013. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci 104:1675–1682.CrossRef
21.
Zurück zum Zitat Han Y, Wu Z, Wu T, Huang Y., Cheng Z., Li X., Sun T., Xie X., Zhou Y., du Z. 2016. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling. Cell Death Dis 7:e2123.CrossRef Han Y, Wu Z, Wu T, Huang Y., Cheng Z., Li X., Sun T., Xie X., Zhou Y., du Z. 2016. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling. Cell Death Dis 7:e2123.CrossRef
22.
Zurück zum Zitat Cao S, Wang Y, Li J, Lv M, Niu H, Tian Y. 2016. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function. Am J Cancer Res 6:2561–2574.PubMedPubMedCentral Cao S, Wang Y, Li J, Lv M, Niu H, Tian Y. 2016. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function. Am J Cancer Res 6:2561–2574.PubMedPubMedCentral
23.
Zurück zum Zitat Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, Lee H, Zhou Z, Gan B, Nakagawa S, Ellis MJ, Liang H, Hung MC, You MJ, Sun Y, Ma L 2018. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 50:1705–1715.CrossRef Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, Lee H, Zhou Z, Gan B, Nakagawa S, Ellis MJ, Liang H, Hung MC, You MJ, Sun Y, Ma L 2018. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 50:1705–1715.CrossRef
24.
Zurück zum Zitat Zhao M, Wang S, Li Q, Ji Q, Guo P, Liu X. 2018. MALAT1: A long non-coding RNA highly associated with human cancers. Oncol Lett 16:19–26.PubMedPubMedCentral Zhao M, Wang S, Li Q, Ji Q, Guo P, Liu X. 2018. MALAT1: A long non-coding RNA highly associated with human cancers. Oncol Lett 16:19–26.PubMedPubMedCentral
25.
Zurück zum Zitat Hajjari M, Salavaty A. 2015. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med 12:1–9.PubMedPubMedCentral Hajjari M, Salavaty A. 2015. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med 12:1–9.PubMedPubMedCentral
26.
Zurück zum Zitat Hirata H, Hinoda Y, Shahryari V, Deng G., Nakajima K., Tabatabai Z.L., Ishii N., Dahiya R. 2015. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res 75:1322–1331.CrossRef Hirata H, Hinoda Y, Shahryari V, Deng G., Nakajima K., Tabatabai Z.L., Ishii N., Dahiya R. 2015. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res 75:1322–1331.CrossRef
27.
Zurück zum Zitat Zhang R, Hardin H, Huang W, Chen J, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV 2017. MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR. Endocr Pathol 28:7–12.CrossRef Zhang R, Hardin H, Huang W, Chen J, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV 2017. MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR. Endocr Pathol 28:7–12.CrossRef
28.
Zurück zum Zitat Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, Tassone P 2018. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol 11:63.CrossRef Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, Tassone P 2018. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol 11:63.CrossRef
29.
Zurück zum Zitat Tang Q, Hann SS. 2018. HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer. Cell Physiol Biochem 47:893–913.CrossRef Tang Q, Hann SS. 2018. HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer. Cell Physiol Biochem 47:893–913.CrossRef
30.
Zurück zum Zitat Ji S, Qin Y, Shi S, Liu X., Hu H., Zhou H., Gao J., Zhang B., Xu W., Liu J., Liang D., Liu L., Liu C., Long J., Zhou H., Chiao P.J., Xu J., Ni Q., Gao D., Yu X. 2015. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. Cell Res 25:561–573.CrossRef Ji S, Qin Y, Shi S, Liu X., Hu H., Zhou H., Gao J., Zhang B., Xu W., Liu J., Liang D., Liu L., Liu C., Long J., Zhou H., Chiao P.J., Xu J., Ni Q., Gao D., Yu X. 2015. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. Cell Res 25:561–573.CrossRef
31.
Zurück zum Zitat Chang YT, Lin TP, Tang JT, Campbell M, Luo YL, Lu SY, Yang CP, Cheng TY, Chang CH, Liu TT, Lin CH, Kung HJ, Pan CC, Chang PC 2018. HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer. Cancer Lett 433:43–52.CrossRef Chang YT, Lin TP, Tang JT, Campbell M, Luo YL, Lu SY, Yang CP, Cheng TY, Chang CH, Liu TT, Lin CH, Kung HJ, Pan CC, Chang PC 2018. HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer. Cancer Lett 433:43–52.CrossRef
32.
Zurück zum Zitat Chakravadhanula M, Ozols VV, Hampton CN, Zhou L, Catchpoole D, Bhardwaj RD. 2014. Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors. Cancer Genet 207:425–428.CrossRef Chakravadhanula M, Ozols VV, Hampton CN, Zhou L, Catchpoole D, Bhardwaj RD. 2014. Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors. Cancer Genet 207:425–428.CrossRef
33.
Zurück zum Zitat Zhang R, Hardin H, Huang W, Buehler D, Lloyd RV. 2018. Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma. Endocr Pathol 29:1–8.CrossRef Zhang R, Hardin H, Huang W, Buehler D, Lloyd RV. 2018. Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma. Endocr Pathol 29:1–8.CrossRef
34.
Zurück zum Zitat Hardin H, Helein H, Meyer K, Robertson S, Zhang R, Zhong W, Lloyd RV 2018. Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs. Lab Invest 98:1133–1142.CrossRef Hardin H, Helein H, Meyer K, Robertson S, Zhang R, Zhong W, Lloyd RV 2018. Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs. Lab Invest 98:1133–1142.CrossRef
35.
Zurück zum Zitat Vijayvergia N, Boland PM, Handorf E, Gustafson KS, Gong Y, Cooper HS, Sheriff F, Astsaturov I, Cohen SJ, Engstrom PF 2016. Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study. Br J Cancer 115:564–570.CrossRef Vijayvergia N, Boland PM, Handorf E, Gustafson KS, Gong Y, Cooper HS, Sheriff F, Astsaturov I, Cohen SJ, Engstrom PF 2016. Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study. Br J Cancer 115:564–570.CrossRef
36.
Zurück zum Zitat Kim ST, Lee SJ, Park SH, Park JO, Lim HY, Kang WK, Lee J, Park YS 2016. Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era. J Cancer 7:1044–1048.CrossRef Kim ST, Lee SJ, Park SH, Park JO, Lim HY, Kang WK, Lee J, Park YS 2016. Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era. J Cancer 7:1044–1048.CrossRef
37.
Zurück zum Zitat Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI. 2018. Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms. Ann Transl Med 6:252.CrossRef Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI. 2018. Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms. Ann Transl Med 6:252.CrossRef
38.
Zurück zum Zitat Yadav R, Kakkar A, Sharma A, Malik PS, Sharma MC. 2016. Study of clinicopathological features, hormone immunoexpression, and loss of ATRX and DAXX expression in pancreatic neuroendocrine tumors. Scand J Gastroenterol 51:994–999.CrossRef Yadav R, Kakkar A, Sharma A, Malik PS, Sharma MC. 2016. Study of clinicopathological features, hormone immunoexpression, and loss of ATRX and DAXX expression in pancreatic neuroendocrine tumors. Scand J Gastroenterol 51:994–999.CrossRef
39.
Zurück zum Zitat Mukhopadhyay S, Dermawan JK, Lanigan CP, Farver CF. 2018. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections. Mod Pathol https://doi.org/10.1038/s41379-018-0122-7. Mukhopadhyay S, Dermawan JK, Lanigan CP, Farver CF. 2018. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections. Mod Pathol https://​doi.​org/​10.​1038/​s41379-018-0122-7.
41.
Zurück zum Zitat Rosenbaum JN, Guo Z, Baus RM, Werner H, Rehrauer WM, Lloyd RV. 2015. INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. Am J Clin Pathol 144:579–591.CrossRef Rosenbaum JN, Guo Z, Baus RM, Werner H, Rehrauer WM, Lloyd RV. 2015. INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. Am J Clin Pathol 144:579–591.CrossRef
42.
Zurück zum Zitat Tanigawa M, Nakayama M, Taira T, Hattori S, Mihara Y, Kondo R, Kusano H, Nakamura K, Abe Y, Ishida Y, Okabe Y, Hisaka T, Okuda K, Fujino K, Ito T, Kawahara A, Naito Y, Yamaguchi R, Akiba J, Akagi Y, Yano H 2018. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor. Med Mol Morphol 51:32–40.CrossRef Tanigawa M, Nakayama M, Taira T, Hattori S, Mihara Y, Kondo R, Kusano H, Nakamura K, Abe Y, Ishida Y, Okabe Y, Hisaka T, Okuda K, Fujino K, Ito T, Kawahara A, Naito Y, Yamaguchi R, Akiba J, Akagi Y, Yano H 2018. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor. Med Mol Morphol 51:32–40.CrossRef
43.
Zurück zum Zitat Rooper LM, Bishop JA, Westra WH. 2018. INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors. Am J Surg Pathol 42:665–671.CrossRef Rooper LM, Bishop JA, Westra WH. 2018. INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors. Am J Surg Pathol 42:665–671.CrossRef
44.
Zurück zum Zitat Xin Z, Zhang Y, Jiang Z, Zhao L, Fan L, Wang Y, Xie S, Shangguan X, Zhu Y, Pan J, Liu Q, Huang Y, Dong B, Xue W 2018. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate. Hum Pathol 79:151–159.CrossRef Xin Z, Zhang Y, Jiang Z, Zhao L, Fan L, Wang Y, Xie S, Shangguan X, Zhu Y, Pan J, Liu Q, Huang Y, Dong B, Xue W 2018. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate. Hum Pathol 79:151–159.CrossRef
45.
Zurück zum Zitat Uri I, Grozinsky-Glasberg S. 2018. Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Clin Diabetes Endocrinol 4:16.CrossRef Uri I, Grozinsky-Glasberg S. 2018. Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Clin Diabetes Endocrinol 4:16.CrossRef
46.
Zurück zum Zitat Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP. 2010. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy. Gastroenterology 139:742–753, 753.e741CrossRef Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP. 2010. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy. Gastroenterology 139:742–753, 753.e741CrossRef
Metadaten
Titel
In Situ Hybridization Analysis of Long Non-coding RNAs MALAT1 and HOTAIR in Gastroenteropancreatic Neuroendocrine Neoplasms
verfasst von
Ying-Hsia Chu
Heather Hardin
Jens Eickhoff
Ricardo V. Lloyd
Publikationsdatum
02.01.2019
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 1/2019
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-018-9564-1

Weitere Artikel der Ausgabe 1/2019

Endocrine Pathology 1/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie